应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
MRK 默沙东
盘前交易 02-19 05:45:15 EST
83.29
+0.28
+0.34%
盘前
83.49
+0.20
+0.24%
05:41 EST
最高
83.59
最低
81.04
成交量
2,590万
今开
81.13
昨收
83.01
日振幅
3.07%
总市值
2,107亿
流通市值
2,104亿
总股本
25.30亿
成交额
21.41亿
换手率
1.03%
流通股本
25.26亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
德银评级现分化：看好吉利德科学(GILD.US)长效HIV药物潜力 警示默沙东(MRK.US)K药专利悬崖风险
智通财经 · 07:00
德银评级现分化：看好吉利德科学(GILD.US)长效HIV药物潜力 警示默沙东(MRK.US)K药专利悬崖风险
港股异动 | 和誉-B(02256)午后涨超6% 默克首付款项助力全年扭亏为盈 机构指公司价值严重低估
智通财经 · 05:41
港股异动 | 和誉-B(02256)午后涨超6% 默克首付款项助力全年扭亏为盈 机构指公司价值严重低估
独家-与美国卫生部长肯尼迪有关的默克疫苗案中途推迟审理
路透中文 · 02-18 19:49
独家-与美国卫生部长肯尼迪有关的默克疫苗案中途推迟审理
独家-默克公司称，与美国卫生与健康部长肯尼迪有关的疫苗案件被推迟处理
路透中文 · 02-18 16:44
独家-默克公司称，与美国卫生与健康部长肯尼迪有关的疫苗案件被推迟处理
默克公司将由公司资深人士接替两名高管
路透中文 · 02-18 12:46
默克公司将由公司资深人士接替两名高管
跨国药企营收前十榜单出炉！有人被“药王”带飞，有人在中国大赚……
国际金融报 · 02-17 14:37
跨国药企营收前十榜单出炉！有人被“药王”带飞，有人在中国大赚……
潜在损失超3000亿美元！近200种药物面临专利悬崖
药时代 · 02-17 12:22
潜在损失超3000亿美元！近200种药物面临专利悬崖
动保巨头年报公布！硕腾2024年盈利约198亿元，默沙东动保营收约430亿元
新牧网 · 02-16
动保巨头年报公布！硕腾2024年盈利约198亿元，默沙东动保营收约430亿元
默沙东的市盈率，只有礼来的1/6
医药财经 · 02-16
默沙东的市盈率，只有礼来的1/6
“百亿美元分子”榜单再扩容 全球药企TOP10重新洗牌
第一财经 · 02-15
“百亿美元分子”榜单再扩容 全球药企TOP10重新洗牌
默沙东的破局之道
药渡 · 02-14
默沙东的破局之道
国家药监局：默沙东注射用头孢洛生他唑巴坦钠获批
广州日报 · 02-14
国家药监局：默沙东注射用头孢洛生他唑巴坦钠获批
诺华将以最高超30亿美元回购自有管线；默沙东新抗菌药在华上市｜医药早参
每日经济新闻 · 02-14
诺华将以最高超30亿美元回购自有管线；默沙东新抗菌药在华上市｜医药早参
默沙东下跌1.21%，报84.635美元/股
金融界 · 02-13
默沙东下跌1.21%，报84.635美元/股
背景资料-肯尼迪担任最高卫生职务，美国疫苗决策悬而未决
路透中文 · 02-13
背景资料-肯尼迪担任最高卫生职务，美国疫苗决策悬而未决
金十数据整理：每日美股市场要闻速递（2月13日 周四）
美港电讯 · 02-13
金十数据整理：每日美股市场要闻速递（2月13日 周四）
默沙东注射用头孢洛生他唑巴坦钠（卓利达）在华获批
南方财经网 · 02-13
默沙东注射用头孢洛生他唑巴坦钠（卓利达）在华获批
港股异动 | 和誉-B(02256)早盘涨超5% 默克首付款项拉动全年业绩 公司预计24年实现扭亏为盈
智通财经 · 02-13
港股异动 | 和誉-B(02256)早盘涨超5% 默克首付款项拉动全年业绩 公司预计24年实现扭亏为盈
BUZZ-默克公司支付 1,500 万美元里程碑款项，Neuphoria Therapeutics 公司股价上涨
路透中文 · 02-12
BUZZ-默克公司支付 1,500 万美元里程碑款项，Neuphoria Therapeutics 公司股价上涨
成全球疫苗销冠但增长疲态已现，默沙东的HPV疫苗能否在中国男性市场突围
第一财经 · 02-12
成全球疫苗销冠但增长疲态已现，默沙东的HPV疫苗能否在中国男性市场突围
加载更多
公司概况
公司名称：
默沙东
所属市场：
NYSE
上市日期：
--
主营业务：
默克制药公司于1970年在新泽西州注册成立。该公司是一家全球医疗保健公司，通过其处方药提供创新的健康解决方案，包括生物疗法、疫苗和动物保健产品。该公司的营运主要以产品为基础进行管理，包括两个经营分部：制药及动物保健国际。
发行价格：
--
{"stockData":{"symbol":"MRK","market":"US","secType":"STK","nameCN":"默沙东","latestPrice":83.29,"timestamp":1739912400000,"preClose":83.01,"halted":0,"volume":25897772,"hourTrading":{"tag":"盘前","latestPrice":83.49,"preClose":83.29,"latestTime":"05:41 EST","volume":1575,"amount":131613.174,"timestamp":1739961694831},"delay":0,"floatShares":2525591263,"shares":2529635645,"eps":6.736324,"marketStatus":"盘前交易","change":0.28,"latestTime":"02-19 05:45:15 EST","open":81.13,"high":83.59,"low":81.04,"amount":2141081596.0370603,"amplitude":0.030719,"askPrice":83.5,"askSize":371,"bidPrice":83.49,"bidSize":100,"shortable":3,"etf":0,"ttmEps":6.736324,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1739975400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":-745790400000,"exchange":"NYSE","adjPreClose":83.29,"dividendRate":0.036979,"preHourTrading":{"tag":"盘前","latestPrice":83.49,"preClose":83.29,"latestTime":"05:41 EST","volume":1575,"amount":131613.174,"timestamp":1739961694831},"postHourTrading":{"tag":"盘后","latestPrice":83.29,"preClose":83.29,"latestTime":"19:59 EST","volume":3089447,"amount":257326213.8894,"timestamp":1739926784203},"volumeRatio":1.2437254057895464,"optionData":{"bulkOrders":[{"symbol":"MRK","call":false,"expireDate":1740114000000,"strike":"90.0","timestamp":1739907227988,"price":7.15,"volume":2075,"amount":1483625,"type":"-"},{"symbol":"MRK","call":false,"expireDate":1740114000000,"strike":"100.0","timestamp":1739907227988,"price":17.15,"volume":1700,"amount":2915500,"type":"+"}]},"impliedVol":0.3038,"impliedVolPercentile":0.868},"requestUrl":"/m/hq/s/MRK","defaultTab":"news","newsList":[{"id":"2512597121","title":"德银评级现分化：看好吉利德科学(GILD.US)长效HIV药物潜力 警示默沙东(MRK.US)K药专利悬崖风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2512597121","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512597121?lang=zh_cn&edition=full","pubTime":"2025-02-19 15:00","pubTimestamp":1739948444,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，美国食品药品管理局周二宣布，已接受吉利德科学为其突破性长效艾滋病疗法lenacapavir递交的新药申请，同时授予这一申请优先审评资格，预计在今年6月19日之前完成审评。若该申请获得批准，lenacapavir将成为首款只需一年两次注射的HIV预防选择，用于HIV感染的暴露前预防。据悉，HIV业务是吉利德科学的基本盘。数据显示，吉利德科学2024年全年营收同比增长6%至287.54亿美元，其中，HIV业务营收同比增长8%至196.12亿美元，占公司总营收的68.2%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1251562.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MRK","GILD"],"gpt_icon":0},{"id":"2512123867","title":"港股异动 | 和誉-B(02256)午后涨超6% 默克首付款项助力全年扭亏为盈 机构指公司价值严重低估","url":"https://stock-news.laohu8.com/highlight/detail?id=2512123867","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512123867?lang=zh_cn&edition=full","pubTime":"2025-02-19 13:41","pubTimestamp":1739943692,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，和誉-B午后涨超6%，截至发稿，涨5.49%，报5.57港元，成交额2212.42万港元。消息面上，和誉将于3月3日举行董事会会议考虑及批准全年业绩。公司此前发布公告，预期去年总收入约为5.04亿元人民币，同比增加约4.85亿元；期内纯利不低于1,000万元，而2023年亏损约为4.32亿元，实现扭亏为盈。主要归因于透过提高业务营运效率来改善成本控制；及pimicotinib的对外许可协议及与默克的首付款项7,000万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1251522.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BJJMRZ35.SGD","LU2106854487.HKD","LU1093756168.USD","LU0985320562.USD","LU2361044949.HKD","LU1291159041.SGD","MRK","SG9999014542.SGD","SG9999015358.SGD","BK4585","LU0238689110.USD","LU0965508806.USD","IE00B2B36J28.USD","02256","LU1037948897.HKD","LU1116320737.USD","LU1934455863.HKD","LU1983299246.USD","LU1057294990.SGD","BK4550","SG9999015341.SGD","LU1066051498.USD","LU0265550359.USD","LU0320765646.SGD","IE0002141913.USD","LU1023059063.AUD","IE000M9KFDE8.USD","LU1069347547.HKD","SG9999001176.USD","LU0234572021.USD","LU1989771016.USD","LU0106261372.USD","LU0006306889.USD","LU1162221912.USD","LU1917777945.USD","LU1929549753.HKD","IE00BN8TJ469.HKD","LU2361044865.SGD","BK4007","LU0965509010.AUD","LU0965509101.SGD","IE00BSNM7G36.USD","LU1066051811.HKD","SGXZ57979304.SGD","LU0203347892.USD","LU1066051225.USD","LU0861579265.USD","LU1989772840.SGD","LU2112291526.USD","SG9999001440.SGD"],"gpt_icon":0},{"id":"2512199998","title":"独家-与美国卫生部长肯尼迪有关的默克疫苗案中途推迟审理","url":"https://stock-news.laohu8.com/highlight/detail?id=2512199998","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512199998?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:49","pubTimestamp":1739908166,"startTime":"0","endTime":"0","summary":"独家-与美国卫生部长肯尼迪有关的默克疫苗案中途推迟审理休庭，新的陪审团将于 9 月重新召集肯尼迪在担任 HHS 职务之前曾帮助组织对默克公司的诉讼默克公司否认索赔，引用科学证据支持加卫苗的安全性修改了第 1 段中的归属，在第 6 段中增加了原告律师的评论，在第 9 段中增加了外部专家的评论Dan Levine/Mike Spector","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250218:nL3T3P91MK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1291159041.SGD","LU2468319806.SGD","LU1093756325.SGD","IE00BN8TJ469.HKD","LU1934455194.USD","LU1057294990.SGD","BK4534","BK4559","LU1989772840.SGD","LU1066053197.SGD","LU1917777945.USD","LU2361044865.SGD","LU0965509010.AUD","LU1585245621.USD","SG9999002224.SGD","LU0265550946.USD","LU0238689110.USD","LU1066051811.HKD","IE00BSNM7G36.USD","LU1989771016.USD","MRK","LU1035773651.USD","LU1983299246.USD","LU0320765646.SGD","LU1116320901.HKD","LU2106854487.HKD","LU0203345920.USD","LU1571399168.USD","LU2324357040.USD","BK4550","LU1974910355.USD","LU0985320562.USD","LU0106261372.USD","LU1069347547.HKD","IE00B4R5TH58.HKD","LU0320765489.SGD","IE000M9KFDE8.USD","SG9999001440.SGD","SGXZ57979304.SGD","SG9999001176.SGD","SG9999015358.SGD","LU0058720904.USD","LU0203347892.USD","IE00BLSP4239.USD","LU1941712264.USD","SG9999013999.USD","LU0006306889.USD","LU2461242641.AUD","BK4588","LU0965509283.SGD"],"gpt_icon":0},{"id":"2512167821","title":"独家-默克公司称，与美国卫生与健康部长肯尼迪有关的疫苗案件被推迟处理","url":"https://stock-news.laohu8.com/highlight/detail?id=2512167821","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512167821?lang=zh_cn&edition=full","pubTime":"2025-02-19 00:44","pubTimestamp":1739897062,"startTime":"0","endTime":"0","summary":"独家-默克公司称，与美国卫生与健康部长肯尼迪有关的疫苗案件被推迟处理Dan Levine/Mike Spector路透社2月18日 - 默克公司表示，该公司与一名起诉该公司的妇女就该公司生产的人类乳头瘤病毒疫苗涉嫌造成伤害一案达成一致意见，停止对该案的审理，该案与美国卫生与公众服务部部长小罗伯特-肯尼迪（Robert F. Kennedy Jr. 默克公司在提供给路透社的一份声明中说，默克公司和原告计划于9月在洛杉矶一家州法院重新召集陪审团。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250218:nL3S3P91GD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","SG9999013999.USD","IE000M9KFDE8.USD","LU1699723380.USD","LU1974910355.USD","BK4585","LU1571399168.USD","IE0002141913.USD","LU0861579265.USD","LU0238689110.USD","LU0965509283.SGD","BK4516","BK4533","LU1093756325.SGD","LU1989772840.SGD","LU1037948541.HKD","SGXZ57979304.SGD","IE00BLSP4452.SGD","LU1066053197.SGD","LU0965508806.USD","SG9999014567.USD","BK4007","LU1066051225.USD","SG9999002232.USD","LU1116320737.USD","LU1934455194.USD","LU1934455277.USD","LU1066051811.HKD","LU1162221912.USD","IE00BFTCPJ56.SGD","LU1430594728.SGD","IE00BSNM7G36.USD","MRK","LU1989772923.USD","LU2023250504.SGD","LU0965509010.AUD","LU0058720904.USD","LU0208291251.USD","LU0122379950.USD","LU0289739699.SGD","SG9999014542.SGD","LU1929549753.HKD","LU1023059063.AUD","LU0320765646.SGD","LU2361044865.SGD","LU0266013472.USD","LU1989771016.USD","SG9999001176.USD","SG9999001176.SGD","LU0320765489.SGD"],"gpt_icon":0},{"id":"2512154861","title":"默克公司将由公司资深人士接替两名高管","url":"https://stock-news.laohu8.com/highlight/detail?id=2512154861","media":"路透中文","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512154861?lang=zh_cn&edition=full","pubTime":"2025-02-18 20:46","pubTimestamp":1739882791,"startTime":"0","endTime":"0","summary":"更新版 1-默克公司将由公司资深人士接替两名高管最后两段增加了执行董事会扩大的细节路透社法兰克福2月18日 - 德国默克公司周二表示，其实验室设备部门和制药部门将从6月起由新的领导层管理，但该公司补充说，其战略保持不变。此外，现任药物研发部门主管 Danny Bar-Zohar 将接替已决定从默克退休的 Peter Guenter，出任制药部门首席执行官。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250218:nL3S3P90Z9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0070302665.USD","LU1093756168.USD","LU0208291251.USD","IE00B4R5TH58.HKD","LU0265550946.USD","LU1066051225.USD","LU1066053197.SGD","LU1929549753.HKD","LU1162221912.USD","MRK","LU1917777945.USD","LU1934455194.USD","LU0320765489.SGD","SG9999001176.USD","SG9999001440.SGD","SG9999002224.SGD","LU2112291526.USD","SG9999014559.SGD","LU0861579265.USD","LU1430594728.SGD","LU2461242641.AUD","LU1699723380.USD","LU0058720904.USD","BK4534","IE0002141913.USD","LU0106261372.USD","IE00B2B36J28.USD","LU0265550359.USD","IE00BLSP4239.USD","LU1291159041.SGD","IE00BBT3K403.USD","LU0266013472.USD","BK4533","LU1066051811.HKD","LU2361044865.SGD","LU0965509101.SGD","LU1023059063.AUD","LU1941712264.USD","LU2106854487.HKD","LU0122379950.USD","LU1974910355.USD","LU1057294990.SGD","LU1066051498.USD","LU1934455863.HKD","LU0203345920.USD","IE00B1BXHZ80.USD","LU2023250843.SGD","SGXZ57979304.SGD","LU1983299246.USD","LU1093756325.SGD"],"gpt_icon":0},{"id":"2512192364","title":"跨国药企营收前十榜单出炉！有人被“药王”带飞，有人在中国大赚……","url":"https://stock-news.laohu8.com/highlight/detail?id=2512192364","media":"国际金融报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512192364?lang=zh_cn&edition=full","pubTime":"2025-02-17 22:37","pubTimestamp":1739803075,"startTime":"0","endTime":"0","summary":"随着越来越多跨国药企发布2024年财报，全球药企业绩TOP10榜单也已于近日落定。“老大哥”强生依然稳坐第一，默沙东K药也保住了“药王”地位。阿斯利康在去年深陷风波，中国市场业绩却创下新高。罗氏、艾伯维、百时美施贵宝、赛诺菲旗下多款产品年销售额突破10亿甚至百亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202502173321357318.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502173321357318.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SGXZ57979304.SGD","LU1989772923.USD","LU0234570918.USD","LU2023250843.SGD","LU1935042991.SGD","LU1989771016.USD","LU1093756168.USD","LU1116320901.HKD","SG9999014575.USD","PFE","LU0985320562.USD","LU2324357040.USD","SG9999013999.USD","LU1066051498.USD","LU0265550359.USD","LU0456855351.SGD","LU0466842654.USD","LU0345769128.USD","LU1883839398.USD","LU1116320737.USD","LU0114720955.EUR","LU1059921491.USD","PSO","MRK","LU0861579265.USD","LU1057294990.SGD","LU1674673691.USD","LU1934455277.USD","LU0266013472.USD","IE0002270589.USD","LU1571399168.USD","SG9999015341.SGD","LU0321505439.SGD","LU0345770308.USD","LU1914381329.SGD","LU2133065610.SGD","LU2347655156.SGD","SG9999002224.SGD","IE000M9KFDE8.USD","LU1778281490.HKD","IE00B3PB1722.GBP","IE00BLSP4452.SGD","LU0098860793.USD","LU1506573853.SGD","BK4599","COO","LU1280957306.USD","LU0912757837.SGD","JNJ","IE00BN8TJ469.HKD"],"gpt_icon":1},{"id":"2512973930","title":"潜在损失超3000亿美元！近200种药物面临专利悬崖","url":"https://stock-news.laohu8.com/highlight/detail?id=2512973930","media":"药时代","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512973930?lang=zh_cn&edition=full","pubTime":"2025-02-17 20:22","pubTimestamp":1739794975,"startTime":"0","endTime":"0","summary":"她指出，未来几年将有近200种药物失去专利保护，其中包括至少69种年销售额超10亿美元的重磅炸弹药物，累计损失销售额超3000亿美元。截止2037年，超25款产品将会面临专利悬崖，以2024年销售额为准，合计潜在损失金额超2364亿美元。就药企而言，默沙东的潜在损失可能最大，但潜在损失最大并不意味着药企所面临的风险就最高。具体而言，BMS继2024年4月宣布15亿美元成本削减计划之后，又于2025年2月再次提出了20亿美元的新削减目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218041359abd29ac0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218041359abd29ac0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765489.SGD","LU0861579265.USD","SG9999013999.USD","LU1941712348.USD","LU0203347892.USD","LU1069347547.HKD","IE0002141913.USD","LU1116320737.USD","IE00BBT3K403.USD","LU0965509283.SGD","LU1917777945.USD","BK4588","LU0265550946.USD","LU0106261372.USD","LU0985320562.USD","LU1929549753.HKD","LU2106854487.HKD","LU2461242641.AUD","LU1023059063.AUD","LU0211331839.USD","LU0203345920.USD","LU0965509010.AUD","BK4516","LU1983299246.USD","SG9999001176.SGD","BK4585","LU0320765646.SGD","IE00B1BXHZ80.USD","LU0122379950.USD","LU1057294990.SGD","SG9999014567.USD","LU0265550359.USD","SG9999014542.SGD","MRK","LU2361045086.USD","LU1941712264.USD","LU0070302665.USD","IE000M9KFDE8.USD","IE00BLSP4452.SGD","LU0266013472.USD","BK4533","LU1989771016.USD","IE0009355771.USD","LU2361044865.SGD","LU0234572021.USD","SG9999014575.USD","LU1035773651.USD","BK4550","LU0006306889.USD","LU2361044949.HKD"],"gpt_icon":0},{"id":"2512596924","title":"动保巨头年报公布！硕腾2024年盈利约198亿元，默沙东动保营收约430亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512596924","media":"新牧网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512596924?lang=zh_cn&edition=full","pubTime":"2025-02-16 18:43","pubTimestamp":1739702626,"startTime":"0","endTime":"0","summary":"另外，近日默沙东公布2024年财报，2024年默沙东总营收641.68亿美元，同比增长7%；2024年来自动物保健部门的营收为59亿美元，同比增长4%。2024 年第四季度净利润为5.81亿美元，摊薄每股收益为1.29美元，分别较报告期增长11%和13%。2024全年净利润为25亿美元，摊薄每股收益为5.47美元，分别较报告基础增长6%和8%。2024年，默沙东总营收641.68亿美元，同比增长7%。展望2025年，默沙东预计全球销售额将在641亿美元至656亿美元之间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216184521a247e74e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216184521a247e74e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRK","ZTS"],"gpt_icon":0},{"id":"2511985218","title":"默沙东的市盈率，只有礼来的1/6","url":"https://stock-news.laohu8.com/highlight/detail?id=2511985218","media":"医药财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511985218?lang=zh_cn&edition=full","pubTime":"2025-02-16 09:27","pubTimestamp":1739669269,"startTime":"0","endTime":"0","summary":"特别是它们的市盈率对比，默沙东的市盈率仅为12.27，而礼来在市值大幅缩水后，市盈率仍高达78，默沙东的市盈率仅为礼来的1/6左右。礼来的市盈率高达75.68倍，这说明投资者对礼来的未来非常看好。相比之下，默沙东的市盈率只有12.27倍，这说明投资者对默沙东的未来增长预期相对较低。希望这篇文章能帮助大家更好地理解市盈率，以及为什么礼来的市盈率会是默沙东的6倍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216094550a2479038&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216094550a2479038&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999017495.SGD","LU2491050154.USD","BK4588","LU1037948541.HKD","LU0708995401.HKD","SG9999014880.SGD","SG9999014898.SGD","LU2023250504.SGD","IE00B4R5TH58.HKD","LU0265550946.USD","LU0320765059.SGD","LU0820561909.HKD","MRK","LU0672654240.SGD","BK4550","LU1366192091.USD","LU0289739699.SGD","LU1069344957.HKD","LU1814569148.SGD","LU2112291526.USD","LU0861579265.USD","LU2602419157.SGD","LU1430594728.SGD","IE00BJT1NW94.SGD","LU2264538146.SGD","LU0882574055.USD","SGXZ81514606.USD","LU0882574139.USD","BK4599","LU2237443465.HKD","SG9999014542.SGD","LU0985320562.USD","LU2361045086.USD","IE00BJJMRZ35.SGD","LU2361044865.SGD","LLY","SGXZ99366536.SGD","BK4559","LU1868836757.USD","LU0114720955.EUR","LU1116320901.HKD","LU1280957306.USD","LU1127390331.HKD","LU2089984988.USD","SG9999014914.USD","SG9999015341.SGD","LU0203345920.USD","LU2023250843.SGD","SG9999014567.USD","LU2491049909.HKD"],"gpt_icon":1},{"id":"2511967398","title":"“百亿美元分子”榜单再扩容 全球药企TOP10重新洗牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2511967398","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511967398?lang=zh_cn&edition=full","pubTime":"2025-02-15 17:31","pubTimestamp":1739611893,"startTime":"0","endTime":"0","summary":"【“百亿美元分子”榜单再扩容 全球药企TOP10重新洗牌】在爆款大单品的带动下，全球药企营收TOP10的榜单座次也发生了变化，礼来凭借替尔泊肽成为第九，而葛兰素史克则掉出榜单。机构预测，2030年全球抗肥胖药物市场整体规模有望达到1000亿美元。随着司美格鲁肽和替尔泊肽的销量狂飙，2025年的头部格局将如何重构，仍然充满了悬念。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202502153320197347.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502153320197347.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2106854487.HKD","BK4559","PFE","IE00BLSP4239.USD","LU0234572021.USD","LU0203345920.USD","LU0320765489.SGD","SG9999013999.USD","IE0002141913.USD","BK4592","LU1883839398.USD","MRK","BK4581","LU1093756325.SGD","IE00B2B36J28.USD","LU0868494617.USD","LU2089984988.USD","SG9999015358.SGD","IE00B4R5TH58.HKD","LU0265550359.USD","LU2023250504.SGD","LU1116320737.USD","LU2468319806.SGD","LU2361045086.USD","LU0965509101.SGD","LU1974910355.USD","SG9999014575.USD","IE00BLSP4452.SGD","SG9999003800.SGD","LU1093756168.USD","LU0965508806.USD","LU1934455194.USD","LU2112291526.USD","IE00B1BXHZ80.USD","BMS","LU0006306889.USD","IE0002270589.USD","LU0306806265.USD","LU1989771016.USD","LU0208291251.USD","LU1571399168.USD","IE00B19Z3581.USD","LU1430594728.SGD","IE00BJT1NW94.SGD","SG9999014567.USD","LU0965509283.SGD","LU0211331839.USD","LU1061106388.HKD","LU0306807586.USD","LU0861579265.USD"],"gpt_icon":1},{"id":"2511649612","title":"默沙东的破局之道","url":"https://stock-news.laohu8.com/highlight/detail?id=2511649612","media":"药渡","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511649612?lang=zh_cn&edition=full","pubTime":"2025-02-15 07:30","pubTimestamp":1739575852,"startTime":"0","endTime":"0","summary":"然而，默沙东的困境已现。在默沙东的3期项目中，大部分是K药以外的药物分子所驱动的。尤其是ADC，是默沙东重点布局领域。ROR1 ADC的竞争格局良好，目前仅有默沙东的Zilovertamab vedotin与基石药业的CS5001进入临床。根据默沙东Q4业绩报告显示，Hyperion和Zenith两项关键研究均达到3期临床主要终点，这两项研究结果对Winrevair未来的市场拓展至关重要。充裕的现金流能够支撑默沙东大量开展对外投资，丰富充实管线组合，其未来充满无限可能，破局之日指日可待。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215073857a24674ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215073857a24674ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","LU0320765489.SGD","LU0985320562.USD","LU1917777945.USD","IE00BJJMRZ35.SGD","LU0965509101.SGD","SG9999001176.SGD","LU1941712264.USD","LU0211331839.USD","SG9999001440.SGD","LU0122379950.USD","LU0289739699.SGD","LU1974910355.USD","IE00BLSP4239.USD","LU1116320901.HKD","BK4516","LU2023250843.SGD","IE00B1BXHZ80.USD","SG9999014542.SGD","LU1983299246.USD","LU2468319806.SGD","LU1934455277.USD","LU1162221912.USD","LU2461242641.AUD","LU0203347892.USD","LU2106854487.HKD","SG9999013999.USD","IE00BFTCPJ56.SGD","LU0070302665.USD","LU1066051225.USD","IE00BN8TJ469.HKD","SG9999015341.SGD","LU0265550946.USD","SG9999001176.USD","LU1699723380.USD","LU1023059063.AUD","LU1989771016.USD","LU0234572021.USD","BK4007","LU0238689110.USD","LU1066051811.HKD","SG9999014559.SGD","LU1037948897.HKD","MRK","IE0002141913.USD","LU0058720904.USD","LU1066051498.USD","SG9999002224.SGD","LU1057294990.SGD","LU1571399168.USD"],"gpt_icon":0},{"id":"2511619106","title":"国家药监局：默沙东注射用头孢洛生他唑巴坦钠获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2511619106","media":"广州日报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511619106?lang=zh_cn&edition=full","pubTime":"2025-02-14 19:36","pubTimestamp":1739532991,"startTime":"0","endTime":"0","summary":"【国家药监局：默沙东注射用头孢洛生他唑巴坦钠获批】中国国家药监局官网发布公示显示：默沙东新型酶抑制剂复合制剂——注射用头孢洛生他唑巴坦钠获批。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502143319779238.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SG9999001176.SGD","IE00BSNM7G36.USD","LU1066051811.HKD","IE00BJT1NW94.SGD","LU1291159041.SGD","BK4585","LU1035773651.USD","LU1974910355.USD","LU2023250843.SGD","LU1585245621.USD","LU1116320901.HKD","SG9999015341.SGD","IE0002141913.USD","LU1066051498.USD","BK4007","LU0208291251.USD","LU0203347892.USD","LU2468319806.SGD","LU1116320737.USD","MRK","LU1571399168.USD","SGXZ57979304.SGD","SG9999001440.SGD","LU1941712264.USD","LU2324357040.USD","LU0058720904.USD","IE000M9KFDE8.USD","IE00B4R5TH58.HKD","BK4559","LU0122379950.USD","LU1989771016.USD","IE00BLSP4452.SGD","SG9999014575.USD","IE00BJJMRZ35.SGD","LU1989772923.USD","LU0006306889.USD","LU1934455277.USD","LU0234572021.USD","LU1037948541.HKD","LU0070302665.USD","LU1989772840.SGD","LU1066053197.SGD","LU2461242641.AUD","LU1023059063.AUD","BK4550","LU0238689110.USD","LU1066051225.USD","LU0106261372.USD","SG9999013999.USD","IE00BLSP4239.USD"],"gpt_icon":1},{"id":"2511502684","title":"诺华将以最高超30亿美元回购自有管线；默沙东新抗菌药在华上市｜医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2511502684","media":"每日经济新闻","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511502684?lang=zh_cn&edition=full","pubTime":"2025-02-14 08:11","pubTimestamp":1739491895,"startTime":"0","endTime":"0","summary":"｜ 2025年2月14日 星期五 ｜NO.1诺华将以最高超30亿美元回购自有管线诺华官宣了今年第一笔公司收购交易，以9.25亿美元预付款及后续至多21.5亿美元里程碑价格拿下Anthos Therapeutics，以加强心血管领域布局。Anthos Therapeutics研发管线中仅有的一款产品abelacimab是由诺华授权注入。与此同时，司美格露天治疗组的体重显著减轻。注射用头孢洛生他唑巴坦钠在中国境内获批，为临床应对耐药菌感染的挑战提供了新的选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214081153a2451f24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214081153a2451f24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0070302665.USD","BK4588","LU0208291251.USD","LU1934455277.USD","LU0211331839.USD","BK4007","LU1066053197.SGD","IE00BFTCPJ56.SGD","BK4516","LU1929549753.HKD","LU2468319806.SGD","LU1162221912.USD","MRK","LU2361044949.HKD","LU1917777945.USD","IE00BN8TJ469.HKD","BK4550","LU0289739699.SGD","LU2112291526.USD","IE00BLSP4452.SGD","LU2461242641.AUD","IE00BSNM7G36.USD","BK4534","IE00B2B36J28.USD","LU0265550359.USD","LU0965508806.USD","LU2361045086.USD","BK4578","IE00BJJMRZ35.SGD","LU0965509283.SGD","LU0266013472.USD","LU2361044865.SGD","SG9999001176.SGD","NVS","LU1116320901.HKD","LU1023059063.AUD","LU1941712264.USD","BK4532","SG9999014575.USD","LU2089984988.USD","LU1061106388.HKD","LU0320765646.SGD","LU1066051498.USD","LU1934455863.HKD","IE00B1BXHZ80.USD","SG9999015358.SGD","LU1983299246.USD","SG9999014567.USD","LU1093756325.SGD","LU1116320737.USD"],"gpt_icon":0},{"id":"2511574700","title":"默沙东下跌1.21%，报84.635美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2511574700","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511574700?lang=zh_cn&edition=full","pubTime":"2025-02-14 04:13","pubTimestamp":1739477626,"startTime":"0","endTime":"0","summary":"2月14日，默沙东(MRK)盘中下跌1.21%，截至04:13，报84.635美元/股，成交10.36亿美元。财务数据显示，截至2024年12月31日，默沙东收入总额641.68亿美元，同比增长6.74%；归母净利润171.17亿美元，同比增长4589.59%。大事提醒：2月12日，默沙东获Guggenheim Investments下调目标价至115美元，最新评级Buy。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/14041348150967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0122379950.USD","LU2023250504.SGD","LU2112291526.USD","SG9999014559.SGD","LU1989771016.USD","LU1066053197.SGD","LU0070302665.USD","LU0965509101.SGD","LU0965509283.SGD","LU0266013472.USD","BK4588","LU2361045086.USD","BK4559","LU0211331839.USD","SGXZ57979304.SGD","LU1585245621.USD","LU2023250843.SGD","IE0002141913.USD","IE00B4R5TH58.HKD","MRK","LU1066051225.USD","LU1066051498.USD","IE000M9KFDE8.USD","LU1116320737.USD","LU1162221912.USD","LU0985320562.USD","SG9999013999.USD","LU0320765646.SGD","SG9999001176.USD","LU1989772840.SGD","LU2468319806.SGD","IE00BBT3K403.USD","LU1069347547.HKD","SG9999002232.USD","IE00BJJMRZ35.SGD","IE00B1BXHZ80.USD","LU1093756168.USD","BK4516","BK4585","SG9999015341.SGD","LU0320765489.SGD","BK4550","IE00B2B36J28.USD","LU1917777945.USD","LU1983299246.USD","SG9999014567.USD","LU2361044865.SGD","LU0234572021.USD","LU2089984988.USD","LU0965508806.USD"],"gpt_icon":0},{"id":"2511795245","title":"背景资料-肯尼迪担任最高卫生职务，美国疫苗决策悬而未决","url":"https://stock-news.laohu8.com/highlight/detail?id=2511795245","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511795245?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:09","pubTimestamp":1739473778,"startTime":"0","endTime":"0","summary":"路透2月13日 - 小罗伯特-肯尼迪是一位疫苗批评家，曾承诺解决慢性病问题，在克服了来自医疗机构和国会议员的阻力并承诺限制其在疫苗政策中的作用后，他于周四被美国参议院确认为卫生部长 。作为负责监管超过 3 万亿美元医疗保健支出的卫生部的负责人，肯尼迪将有权监管包括美国食品药品管理局 和疾病控制与预防中心 在内的机构。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250213:nL4T3P41V2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1645745479.HKD","LU0971552673.USD","LU0757432116.USD","SG9999015358.SGD","LU1302929846.USD","LU0861579265.USD","LU0234572021.USD","LU1880407215.USD","SG9999002232.USD","LU0211326755.USD","LU0114720955.EUR","LU1037948897.HKD","LU1162221912.USD","LU0949170426.SGD","LU1571399168.USD","LU1934455863.HKD","LU2112291526.USD","LU1267930227.SGD","LU2106854487.HKD","IE0034235071.USD","MRK","GSK.UK","LU2023250504.SGD","IE000M9KFDE8.USD","LU0882574055.USD","LU0321505868.SGD","MRNA","LU0889565080.SGD","LU1989771016.USD","SG9999002224.SGD","LU0526926950.USD","BK4534","LU0310799852.SGD","LU1051770623.HKD","LU1078025761.USD","LU2361044865.SGD","03165","BK4585","AZN.UK","LU1084165304.USD","LU0661504455.SGD","LU1003077747.HKD","LU0029864427.USD","NVAX","SG9999001176.SGD","LU0575583348.USD","SG9999013999.USD","LU1093756168.USD","LU1069347547.HKD","LU0058720904.USD"],"gpt_icon":1},{"id":"2511540781","title":"金十数据整理：每日美股市场要闻速递（2月13日 周四）","url":"https://stock-news.laohu8.com/highlight/detail?id=2511540781","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511540781?lang=zh_cn&edition=full","pubTime":"2025-02-13 21:46","pubTimestamp":1739454406,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BABA","LU0737861699.HKD","TWmain","LU0594300179.USD","MRK","IE00BK4W5L77.USD","LU1251922891.USD","AAPL","89988","TSLA","03145","ABBV","INTC","LU0308772762.SGD","MACW.SI","TSYW.SI","BK4514","LU0052750758.USD","PPI","HBBD.SI","LU0316494557.USD","BIDU","LU2463028550.USD","USJW.SI","GOOGL","HMC","LU1244550494.USD","TSLL","LU0238689110.USD","SG9999001176.SGD","09988","LU0501845795.SGD","CSCO","LU2065169927.USD","EWT","161631","LU1127390331.HKD","GOOG","LU0106252389.USD","LU0396098781.USD","LU2065171402.SGD","LU1048588211.SGD","LU0890818403.SGD","TSM","LU0061474705.USD","LU1642822529.SGD","NSANY","LU1894683348.USD","LU1037948541.HKD"],"gpt_icon":0},{"id":"2511696517","title":"默沙东注射用头孢洛生他唑巴坦钠（卓利达）在华获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2511696517","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511696517?lang=zh_cn&edition=full","pubTime":"2025-02-13 18:09","pubTimestamp":1739441380,"startTime":"0","endTime":"0","summary":"默沙东注射用头孢洛生他唑巴坦钠（卓利达）在华获批","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502133318546398.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4533","LU1116320737.USD","LU0058720904.USD","LU0265550359.USD","LU0211331839.USD","IE0009355771.USD","LU1023059063.AUD","SG9999002224.SGD","LU2106854487.HKD","LU1162221912.USD","LU0965509101.SGD","LU1037948541.HKD","LU2324357040.USD","LU0122379950.USD","LU0965509010.AUD","LU1934455277.USD","LU0070302665.USD","SG9999014567.USD","LU1066051811.HKD","BK4588","SG9999014575.USD","LU1093756325.SGD","LU0320765489.SGD","LU0106261372.USD","IE000M9KFDE8.USD","IE00BLSP4239.USD","LU1291159041.SGD","LU1430594728.SGD","LU1974910355.USD","IE00B2B36J28.USD","LU0320765646.SGD","LU2461242641.AUD","SG9999013999.USD","IE00BBT3K403.USD","LU0965508806.USD","IE00B4R5TH58.HKD","MRK","LU2468319806.SGD","SGXZ57979304.SGD","LU0289739699.SGD","BK4550","LU1989772840.SGD","LU1057294990.SGD","IE00BN8TJ469.HKD","LU1066051225.USD","LU1571399168.USD","LU1934455194.USD","BK4007","SG9999001440.SGD","LU0965509283.SGD"],"gpt_icon":0},{"id":"2511255480","title":"港股异动 | 和誉-B(02256)早盘涨超5% 默克首付款项拉动全年业绩 公司预计24年实现扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2511255480","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511255480?lang=zh_cn&edition=full","pubTime":"2025-02-13 10:03","pubTimestamp":1739412226,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，和誉-B(02256)早盘涨超5%，截至发稿，涨5.04%，报5.21港元，成交额747.02万港元。消息面上，和誉此前发布盈喜，预期去年总收入约为5.04亿元人民币，同比增加约4.85亿元；及溢利不低于1,000万元，而2023年亏损约为4.32亿元，实现扭亏为盈。公告称，除了透过提高业务营运效率来改善成本控制外，预计总收入的增长及扭亏为盈亦主要归因于pimicotinib(ABSK021)的对外许可协议及与默克公司的首付款项7000万美元(人民币4.97亿元)，其对截至2024年12月31日止年度的收入作出重大贡献。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1249197.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0122379950.USD","LU1093756325.SGD","IE00BN8TJ469.HKD","SG9999015341.SGD","LU1037948541.HKD","LU1061106388.HKD","BK4007","BK4559","BK1161","LU1116320737.USD","IE00BLSP4452.SGD","LU0266013472.USD","LU1934455863.HKD","SG9999001176.USD","IE00BBT3K403.USD","SG9999014567.USD","LU1585245621.USD","SG9999002224.SGD","LU0265550946.USD","LU0238689110.USD","LU1066051811.HKD","IE00BSNM7G36.USD","MRK","LU2488822045.USD","LU2361044949.HKD","IE00BJJMRZ35.SGD","LU0861579265.USD","IE00B1BXHZ80.USD","LU1941712348.USD","LU1066051498.USD","LU0203345920.USD","BK4516","LU0289739699.SGD","LU2324357040.USD","LU1989772923.USD","IE00B4R5TH58.HKD","IE0002141913.USD","LU1066051225.USD","SG9999001176.SGD","SG9999002232.USD","LU0058720904.USD","LU1037948897.HKD","LU1929549753.HKD","SG9999015358.SGD","IE00BLSP4239.USD","02256","LU1941712264.USD","LU0006306889.USD","BK4588","LU0070302665.USD"],"gpt_icon":0},{"id":"2510309152","title":"BUZZ-默克公司支付 1,500 万美元里程碑款项，Neuphoria Therapeutics 公司股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2510309152","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510309152?lang=zh_cn&edition=full","pubTime":"2025-02-12 23:50","pubTimestamp":1739375414,"startTime":"0","endTime":"0","summary":"BUZZ-默克公司支付 1,500 万美元里程碑款项，Neuphoria Therapeutics 公司股价上涨2月12日 - ** 总部位于马萨诸塞州的药物开发商Neuphoria Therapeutics NEUP.O早盘上涨3.31%，至4.65美元。** 默克公司一项治疗阿尔茨海默病痴呆症的中期研究开始后，该公司将获得1500万美元的里程碑付款。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nL4T3P31EK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","SG9999014542.SGD","LU1037948897.HKD","LU1941712264.USD","LU2361045086.USD","SG9999014567.USD","LU1023059063.AUD","LU2461242641.AUD","IE00BSNM7G36.USD","LU0058720904.USD","LU0122379950.USD","SG9999014575.USD","LU0265550359.USD","LU2324357040.USD","LU1989772923.USD","BK4516","IE0009355771.USD","IE00BLSP4239.USD","LU1941712348.USD","NEUP","LU0234572021.USD","LU2023250504.SGD","LU0006306889.USD","SG9999014559.SGD","LU2468319806.SGD","IE00BJT1NW94.SGD","IE00BLSP4452.SGD","LU1066053197.SGD","LU0203347892.USD","LU1430594728.SGD","IE000M9KFDE8.USD","LU1585245621.USD","LU1699723380.USD","SG9999015358.SGD","LU1057294990.SGD","SG9999001176.SGD","MRK","LU1061106388.HKD","LU1934455277.USD","LU0203345920.USD","LU0985320562.USD","LU1069347547.HKD","LU1116320901.HKD","LU1291159041.SGD","LU0238689110.USD","LU2106854487.HKD","IE0002141913.USD","LU1066051225.USD","LU0320765489.SGD","LU0289739699.SGD"],"gpt_icon":0},{"id":"2510929373","title":"成全球疫苗销冠但增长疲态已现，默沙东的HPV疫苗能否在中国男性市场突围","url":"https://stock-news.laohu8.com/highlight/detail?id=2510929373","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510929373?lang=zh_cn&edition=full","pubTime":"2025-02-12 19:35","pubTimestamp":1739360105,"startTime":"0","endTime":"0","summary":"85.83亿美元，这是默沙东近期公布的旗下HPV疫苗（四价以及九价HPV疫苗）在2024年的销售额。在2024年全球疫苗销售榜单中，默沙东的HPV疫苗取代辉瑞新冠疫苗，位列第一，但销售额称霸的同时，增长疲态已显现。2024年，默沙东的HPV疫苗销售额以3%的同比下滑，告别了过去多年高歌猛进的态势，这跟中国市场销售下滑密不可分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202502123317454160.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502123317454160.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1093756325.SGD","LU1066053197.SGD","BK4516","LU1069347547.HKD","BK4533","LU0122379950.USD","LU0289739699.SGD","LU1917777945.USD","SG9999001176.SGD","BK4585","LU0070302665.USD","LU0234572021.USD","LU0265550359.USD","LU1066051811.HKD","LU2112291526.USD","SG9999014575.USD","IE00BJJMRZ35.SGD","LU1929549753.HKD","LU0985320562.USD","LU1989772923.USD","LU1983299246.USD","LU1291159041.SGD","LU0238689110.USD","LU1093756168.USD","LU0965508806.USD","LU2361044865.SGD","LU0965509010.AUD","BK4007","SG9999014559.SGD","LU0320765646.SGD","MRK","LU1066051498.USD","IE00BLSP4239.USD","LU1035773651.USD","LU2023250843.SGD","LU1974910355.USD","LU1162221912.USD","LU2106854487.HKD","SG9999002224.SGD","LU2461242641.AUD","BK4588","LU0965509101.SGD","LU1057294990.SGD","SGXZ57979304.SGD","SG9999001176.USD","SG9999014542.SGD","LU1116320901.HKD","IE00B1BXHZ80.USD","SG9999001440.SGD","LU0203347892.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.merck.com","stockEarnings":[{"period":"1week","weight":-0.0376},{"period":"1month","weight":-0.1494},{"period":"3month","weight":-0.1452},{"period":"6month","weight":-0.2854},{"period":"1year","weight":-0.3482},{"period":"ytd","weight":-0.1627}],"compareEarnings":[{"period":"1week","weight":0.0102},{"period":"1month","weight":0.0233},{"period":"3month","weight":0.0355},{"period":"6month","weight":0.0994},{"period":"1year","weight":0.2242},{"period":"ytd","weight":0.0434}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"默克制药公司于1970年在新泽西州注册成立。该公司是一家全球医疗保健公司，通过其处方药提供创新的健康解决方案，包括生物疗法、疫苗和动物保健产品。该公司的营运主要以产品为基础进行管理，包括两个经营分部：制药及动物保健国际。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.009524},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.00388},{"month":3,"riseRate":0.636364,"avgChangeRate":-0.002321},{"month":4,"riseRate":0.622222,"avgChangeRate":0.018595},{"month":5,"riseRate":0.644444,"avgChangeRate":0.018719},{"month":6,"riseRate":0.511111,"avgChangeRate":0.01265},{"month":7,"riseRate":0.488889,"avgChangeRate":0.003443},{"month":8,"riseRate":0.488889,"avgChangeRate":0.001677},{"month":9,"riseRate":0.533333,"avgChangeRate":-0.006327},{"month":10,"riseRate":0.533333,"avgChangeRate":0.018591},{"month":11,"riseRate":0.711111,"avgChangeRate":0.028573},{"month":12,"riseRate":0.6,"avgChangeRate":0.013993}],"exchange":"NYSE","name":"默沙东","nameEN":"Merck"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.1","shortVersion":"4.31.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"默沙东,MRK,默沙东股票,默沙东股票老虎,默沙东股票老虎国际,默沙东行情,默沙东股票行情,默沙东股价,默沙东股市,默沙东股票价格,默沙东股票交易,默沙东股票购买,默沙东股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}